In breast cancer, DOK7 overexpression could suppress the cell proliferation and mobility by dampening phosphoinositide 3-kinase (PI3K)/Protein kinase B (AKT) signaling pathway [20]. This evidence concerns the gene AKT1 and breast cancer.